21 Jul 2022 | 02:45 PM GMT

Partnership Roadmap for Pharma - DTx Collaborations

Participants:

Francesca Wuttke Founder & CEOnen Health
Francesca Wuttke
Founder & CEOnen Health
Ricardo C. Berrios Co-Founder & CEOAdhera Health, Inc.
Ricardo C. Berrios
Co-Founder & CEOAdhera Health, Inc.
Adriano Garcez Director, DTx/SaMD Evidence GenerationZS Associates
Adriano Garcez
Director, DTx/SaMD Evidence GenerationZS Associates
Ale Solano Software DeveloperOpenRegulatory
Ale Solano
Software DeveloperOpenRegulatory
Anna-Maria Heidinger Head of Digital Innovation HubDaiichi Sankyo Europe
Anna-Maria Heidinger
Head of Digital Innovation HubDaiichi Sankyo Europe
Brian Mahony Chief Commercial OfficerOutput Sports
Brian Mahony
Chief Commercial OfficerOutput Sports
Chris Wasden Chief Strategy OfficerTwill
Chris Wasden
Chief Strategy OfficerTwill
Gregoire Guillet Chief Business and Value OfficerWeHealth Digital Medicine
Gregoire Guillet
Chief Business and Value OfficerWeHealth Digital Medicine
Jane Myles Director, Co-Lead, Priority InitiativeDecentralized Trials & Research Alliance
Jane Myles
Director, Co-Lead, Priority InitiativeDecentralized Trials & Research Alliance
Katie Cannon Director - Strategic PartnershipsAvegen Health
Katie Cannon
Director - Strategic PartnershipsAvegen Health
Martin Svorc Director | Global Business Dev. FertilityMerck KGaA
Martin Svorc
Director | Global Business Dev. FertilityMerck KGaA
Rasit Senol Sales SpecialistBI Technology Qlik Master Reseller
Rasit Senol
Sales SpecialistBI Technology Qlik Master Reseller
Sid Desai Co-Founder & CEONovobeing
Sid Desai
Co-Founder & CEONovobeing

About this Meeting

What is the partnership roadmap for pharma and digital therapeutics (DTx) companies collaborations? 

The number of partnerships between DTx and pharma have accelerated in recent years and yet we are still in the exploratory phase of this relationship. Successful partnerships have shown us the potential benefits of a DTx-pharma relationship, but there are still numerous failures within collaborations that also must be examined. Given the cultural clash, DTx and pharma collaborations need to have a clear roadmap from the beginning to ensure all teams are aligned and go in the same direction, and thus, prevent shortcomings seen before. Join this session to have a peer-to-peer conversation about the partnership roadmap for pharma-DTx collaborations: 

  • Once a deal between the DTx and pharma company is closed and we have a clear roadmap on the table, what comes next? How do we ensure the partnership will succeed? How flexible do we need to be along the journey?  
  • What can we learn from unsuccessful partnerships to help us build better partnership roadmaps?  
  • How can we build the internal operations that will support partnerships with DTx companies? Who within the pharma company needs to lead these operational changes? 
  • How can pharma companies reach parallel paths of procurement, legal, data privacy and compliance to make a partnership work?